NCT04362371View on ClinicalTrials.gov

Post Marketing Follow Up Study To Evaluate Performance Safety Quality of Menopausal Transition Women Treated With Ainara

NACompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

June 27, 2019

Primary Completion Date

December 9, 2019

Study Completion Date

December 9, 2019

Conditions
Vaginal Disease
Interventions
DEVICE

Ainara

1 g at each administration

Trial Locations (1)

Unknown

Fizio Center, Timișoara

Sponsors

Lead Sponsor

Italfarmaco
All Listed Sponsors
collaborator

Opera CRO, a TIGERMED Group Company

OTHER

lead

Italfarmaco

INDUSTRY